drugset / Trial / NCT00621907

Study : LEVOBUPIVACAINE Versus Placebo

NCT00621907

Phase 3 Completed 140 enrolled University Hospital of Saint-Etienne
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The locoregional anaesthesia is increasingly important in surgical practice, often allowing to simplify per- and post-operative analgesia. caesarian occurs in 20 % of delivery leading to a longer hospitalization because of the pain resulting from the surgery. The Levobupivacaïne (Chirocaïne) administered through catheters placed in the caesarean scars, showed its efficiency in post-operative analgesia. Method : realization of a double blind prospective randomized study, control versus placebo Purpose : to show that the local administration of a unique dose of analgesia reduce the post-operative pain with a little or non-invasive technique

Timeline

Start
2008-03
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 150 mg

Indications

No indication recorded.